Insider Trading & Ownership of Jay M. Moyes

Location
Los Angeles, CA
Summary
The estimated net worth of Jay M. Moyes is at least $378,923 dollars as of 25 Feb 2026. Jay M. Moyes is the Chief Financial Officer of SERA PROGNOSTICS, INC. and owns shares of SERA PROGNOSTICS, INC. (SERA) stock worth about $186K. Jay M. Moyes is the Director of PUMA BIOTECHNOLOGY, INC. and owns shares of PUMA BIOTECHNOLOGY, INC. (PBYI) stock worth about $181.3K. Jay M. Moyes is the Director of Sintx Technologies, Inc. and owns shares of Sintx Technologies, Inc. (SINT) stock worth about $11.6K.
Signature
/s/ Kevin Ontiveros, by power of attorney
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jay M. Moyes and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Jay M. Moyes has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $378,923.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: SERA PROGNOSTICS, INC. ($185,989).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jay M. Moyes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SERA SERA PROGNOSTICS, INC. Chief Financial Officer $185,989 07 Jun 2023
PBYI PUMA BIOTECHNOLOGY, INC. Director $181,294 -$74,800 -29% 13 Jun 2025
SINT Sintx Technologies, Inc. Director $11,640 +$13,666 +117% 23 Feb 2026
ACHV ACHIEVE LIFE SCIENCES, INC. Director 31 May 2022
BCDA BioCardia, Inc. Director 08 Dec 2025

Insider Transactions Reported by Jay M. Moyes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .